| [1] |
Gong Yan, Chen Honglei.
Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer
[J]. Journal of International Oncology, 2024, 51(3): 186-190.
|
| [2] |
Yang Ya, Wang Huili, Liu Yan, Guo Jinfeng, Wang Chunxia, Lyu Min, Shan Changping.
Effects of GCSH gene on proliferation and apoptosis of gastric cancer SNU-1 cells
[J]. Journal of International Oncology, 2023, 50(5): 257-262.
|
| [3] |
Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.
lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway
[J]. Journal of International Oncology, 2023, 50(4): 202-207.
|
| [4] |
Yang Ya, Ning Xiaofei, Li Bingliang, Yao Hui, Shan Changping, Lyu Min.
Study on the mechanism of procyanidin mediated anti gastric cancer SNU-1 cell line by inducing the production of reactive oxygen species
[J]. Journal of International Oncology, 2022, 49(5): 257-262.
|
| [5] |
Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.
MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2
[J]. Journal of International Oncology, 2022, 49(4): 193-198.
|
| [6] |
Jin Jiahui, Chen Cunhai, Ma Xuezhen.
Effects of radiation-associated miRNA in radiotherapy for breast cancer
[J]. Journal of International Oncology, 2022, 49(12): 735-738.
|
| [7] |
Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.
Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer
[J]. Journal of International Oncology, 2022, 49(11): 681-686.
|
| [8] |
Cai Jiahui, Rong Guanghong.
Mechanism and clinical significance of YAP in the progression of gastric cancer
[J]. Journal of International Oncology, 2022, 49(11): 687-691.
|
| [9] |
Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.
Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis
[J]. Journal of International Oncology, 2022, 49(1): 45-50.
|
| [10] |
Hong Anlan, Cao Meng, Wang Yan, Fang Fang.
Research progress on lncRNAs as members of ceRNA network in melanoma
[J]. Journal of International Oncology, 2022, 49(1): 61-64.
|
| [11] |
Hu Guangyue, Yin Hong, Zhang Hui, Luo Hong.
Efficacy predictors of immune checkpoint inhibitors in the treatment of metastatic gastric cancer
[J]. Journal of International Oncology, 2021, 48(8): 498-501.
|
| [12] |
Liu Pei, Pu Jiaze, Huang Wen, Wang Fei.
Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis
[J]. Journal of International Oncology, 2021, 48(7): 409-414.
|
| [13] |
Wang Yang, Liu Qian, Long Hui, Wu Qingming.
Research status of fecal detection for colorectal cancer markers
[J]. Journal of International Oncology, 2021, 48(7): 441-444.
|
| [14] |
Cheng Yiming, Li Gang, Wang Zhenming, Lyu Qianwen, Li Shirong.
Value of serum miR-196a-5p and miR-105-5p in differential diagnosis of benign and malignant pulmonary nodules
[J]. Journal of International Oncology, 2021, 48(5): 282-286.
|
| [15] |
Deng Bo'er, Kong Weimin.
Epigenetic research progress of endometrial cancer
[J]. Journal of International Oncology, 2021, 48(3): 184-188.
|
